black metal fence on seashore during daytime

Certifications

AIM Research is proud to hold independent certification through The Global Quality Standard for Clinical Research Sites (GCSA), an internationally recognised benchmark for quality, governance, operational excellence and participant-focused clinical research delivery.

GCSA Site Certification is awarded by the International Accrediting Organization for Clinical Research (IAOCR), developed in close collaboration with global stakeholders across pharma, biotech and CROs. This makes Aim Research one of only a small number of clinical research sites in Australia to hold this certification.

GCSA Certified

The GCSA certification is awarded to organisations that demonstrate adherence to globally benchmarked best-practice standards and modern ICH-GCP principles. It goes beyond regulatory compliance to encompass the systems, processes, culture, and people that underpin the delivery of high-quality clinical research.

GCSA Certification evidences our proactive, risk-aware and quality-by-design approach to clinical trial conduct, confirming that our operational systems, governance structures and quality processes are designed to support compliant, efficient and participant-centred research delivery.

IAOCR Global Best Practices Board

As part of this achievement, Aim Research has been invited to join the IAOCR Global Best Practices Board, contributing to the ongoing development of international quality standards alongside industry leaders from around the world.

“The certification process was an extremely positive and constructive experience, providing valuable insights and reinforcing our commitment to quality, participant care and continuous improvement. We are delighted to have our standards recognised through this internationally respected accreditation.”

– Dr Claire Morbey, Director of Research

Read the full announcement on our News/Resources